Table 1 Overview of all urinoids generated in this project giving an overview of all patients.

From: Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation

Patient #

Line

Classification

Subclassification

Gender

Passage number

4

UBTOR4.2

MIBC

ypT1G3 Papillary UCC

M

P16

5

UBTOR5

MIBC

pTisN0MxR0

F

P13

6

UBTOR6.1

NMIBC

pT1G3 Papillary UCC

F

P6

7

UBTOR7.1

NMIBC

pT1G3 Papillary UCC

M

P10

8

UBTOR8

MIBC

pTisN0MxR0

M

P5

21

UBTOR21

MIBC

pT3N0MxR0 SCC + PI

M

P11

36

UBTOR36.2

NMIBC

pT1G2-3 Papillary UCC

M

P7

36

UBTOR36.3

NMIBC

pT1G2-3 Papillary UCC

M

P5

38

UBTOR38

NMIBC

pTaG1-2 Papillary UCC

M

P5

41

UBTOR41

MIBC

pT2bG3N0 UCC

M

P8

45

UBTOR45

MIBC

pT2G3 UCC

M

P7

57

UBTOR57

NMIBC

pT1G3 Papillary UCC

M

P5

  1. UCC urothelial carcinoma, SCC squamous cell carcinoma, PI peritoneal invasion.
  2. Table overview of all urinoids generated in this project giving an overview of all patients, urinoids generated, TNM classification, pathological stage of the tumour, gender and passage of the organoid line. All lines were stocked at lower passage numbers than the indicated passage number. Lines were taken out of long-term culture at indicated passage number.
Back to article page